The cGAS-STING pathway can potentially inhibit immune escape by IFNβ1/CCL5-mediated infiltration of CTLs and can also promote tumor growth by activating VEGF signaling and immune checkpoints such as the PD-1 axis [85,87]. Here, CCL5 is linked to neoplasm.